Open access · OA
via OpenAlex
Aging and osteoporosis in breast and prostate cancer
Ari M. Vanderwalde, Arti Hurria
CA A Cancer Journal for Clinicians · 2011 · ▲ 73 citations
Abstract
As people with cancer survive longer, and as the US population ages, skeletal effects of cancer treatment are becoming more pronounced. This is particularly true for breast and prostate cancer survivors because of the high average age of patients with these malignancies, the propensity of older adults in general toward the development of osteoporosis, and the wide use of therapeutic agents in these cancers that negatively impact bone health. Various therapies used in the treatment and prevention of cancer may cause decreases in bone mineral density and an increased risk of debilitating fracture, even in the absence of bone metastases. Aging is both a baseline risk factor in the development of osteoporosis and bony fracture, as well as a predictor of poor outcome after fracture. A variety of mechanisms may be responsible for the development of bone loss in patients with breast or prostate cancer. Cytotoxic chemotherapy may directly exert long-term toxic effects on bone. Chemotherapy and endocrine therapy can induce hypogonadism, leading to an increased rate of bone loss. The risk of skeletal events in older adults due to cancer therapy should be appreciated by all oncologists, geriatricians, and internists. The following review may serve as a guide to the skeletal side effects of cancer therapy in older adults with breast or prostate cancer, how to screen for treatment-related bone loss, and how to best prevent and/or treat skeletal events.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3322/caac.20103
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Vanderwalde, A.M., & Hurria, A. (2011). Aging and osteoporosis in breast and prostate cancer. <em>CA A Cancer Journal for Clinicians</em>. https://doi.org/10.3322/caac.20103
Vancouver
Vanderwalde AM, Hurria A. Aging and osteoporosis in breast and prostate cancer. CA A Cancer Journal for Clinicians. 2011. doi:10.3322/caac.20103.
BibTeX
@article{ari2011Aginga,
title = {Aging and osteoporosis in breast and prostate cancer},
author = {Ari M. Vanderwalde and Arti Hurria},
journal = {CA A Cancer Journal for Clinicians},
year = {2011},
doi = {10.3322/caac.20103},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Institute on Aging (NIA) 2001
Open access · US-GOV
Testosterone Effects on Bone and Frailty in Men With Osteoporosis
International Conference on Biomedical Engineering and Technology (ICBET) 2020
Citation only
The Role of Estrogen in Bone Turnover with Aging and Age-related Osteoporosis
Endocrinology and Metabolism Clinics of North America 2005
Citation only
Pathophysiology of Age-Related Bone Loss and Osteoporosis
Springer eBooks 2018
Citation only
The Relationship of Peak Bone Mass, Aging, and Bone Loss to Osteoporosis and Fragility Fractures
Elsevier eBooks 2021
Citation only
Osteoporosis and bone loss
Best practice & research. Clinical rheumatology 2026
Citation only